Dr. Ursa A. Brown-Glaberman
Claim this profileUniversity of New Mexico Cancer Center
Studies Breast Cancer
Studies Gallbladder Cancer
20 reported clinical trials
45 drugs studied
About Ursa A. Brown-Glaberman
Education:
- Earned an MD (Doctor of Medicine) from an unspecified institution.
Experience:
- Serves as an Associate Professor in the Department of Internal Medicine, Division of Hematology/Oncology, at the UNM School of Medicine.
- Holds the position of Medical Director for Clinical Research at the University of New Mexico Comprehensive Cancer Center (UNMCCC).
- Specializes in the treatment of breast and gastrointestinal cancers.
- Awarded the National Cancer Institute's Cancer Clinical Investigator Team Leadership Award in 2017.
- Leads both the Breast and Gastrointestinal Cancer Programs at UNMCCC.
Area of expertise
1Breast Cancer
Stage IV
HER2 negative
Stage III
2Gallbladder Cancer
Stage IV
Stage III
RAF positive
Affiliated Hospitals
Clinical Trials Ursa A. Brown-Glaberman is currently running
Marker-Directed Monitoring
for Breast Cancer
This trial studies if using blood tests to decide when to do scans is as effective as the standard way for monitoring patients with a specific type of breast cancer that has spread. The blood tests act like an early warning system for cancer activity.
Recruiting1 award N/A
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
More about Ursa A. Brown-Glaberman
Clinical Trial Related5 years of experience running clinical trials · Led 20 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Ursa A. Brown-Glaberman has experience with
- Cisplatin
- Pembrolizumab
- Palbociclib
- Fluorouracil
- Gemcitabine
- Gemcitabine Hydrochloride
Breakdown of trials Ursa A. Brown-Glaberman has run
Breast Cancer
Gallbladder Cancer
Breast cancer
Bile Duct Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ursa A. Brown-Glaberman specialize in?
Ursa A. Brown-Glaberman focuses on Breast Cancer and Gallbladder Cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are HER2 negative.
Is Ursa A. Brown-Glaberman currently recruiting for clinical trials?
Yes, Ursa A. Brown-Glaberman is currently recruiting for 5 clinical trials in Albuquerque New Mexico. If you're interested in participating, you should apply.
Are there any treatments that Ursa A. Brown-Glaberman has studied deeply?
Yes, Ursa A. Brown-Glaberman has studied treatments such as Cisplatin, Pembrolizumab, Palbociclib.
What is the best way to schedule an appointment with Ursa A. Brown-Glaberman?
Apply for one of the trials that Ursa A. Brown-Glaberman is conducting.
What is the office address of Ursa A. Brown-Glaberman?
The office of Ursa A. Brown-Glaberman is located at: University of New Mexico Cancer Center, Albuquerque, New Mexico 87131 United States. This is the address for their practice at the University of New Mexico Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.